Corporate Advisory

PharmaDeals v4

PharmaTelevision

Industry Insight and Intelligence

 

Deal-making declines by 18%

Oxford, UK 25 Jan 2012 - Overall pharmaceutical deal-making activity fell by 18% in 2011 as pharmaceutical companies cut R&D expenditure.

Read the full press release

May 2012: Licensing Workshop

Next workshop: Calculating and Negotiating Financial Terms for License Agreements 28-29 May 2012, Oxford, UK.

Find out more

PharmaVentures News

PharmaVentures acts as exclusive advisor to Sanofi-aventis in landmark divestment deal with Covance

Find out more

New Report Published

The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector

Find out more

PharmaVentures News

PharmaVentures acts as advisor and broker to Dr Reddy’s to identify and secure product marketing opportunities for the Russian/CIS market

Press Release

PharmaDeals V4

Visit our PharmaDeals website to find out more and sign up for a free trial or demo.

PharmaDeals V4

PharmaVentures White Paper

Download a PDF of “Competitive Deal Activity Profiling (CDAP©)”

Read White Paper

PharmaVentures News

PharmaVentures engaged by Avexa to Assist in the Out-licensing of Apricitabine

Read more>

Recent Clients Include

Recent Previous Clients Include